Connect with us

COVID19

JEE Mains To Be Held From July 18 to 23; NEET On July 26

The HRD Minister said that a decision will be taken on pending CBSE 10th and 12th Class board exams soon.

Published

on

NEW DELHI: Human Resources Development Minister Ramesh Pokhriyal Nishank on May 5 announced that the Joint Entrance Examination (JEE-Mains) for entrance to Indian Institute of Technology (IIT) will be held from July 14 to 23 and National Eligibility-cum-Entrance Test (NEET) for entry into medical schools across the nation will be held on July 26.

More than 15 lakh students across the country have registered for NEET this year, whereas more than nine lakh have registered for JEE Mains, the entrance exam for all engineering colleges except the IITs.

Interacting with students from across the country, the education minister said that the JEE-Advanced will be held in August and the dates will be announced soon.


The HRD Ministry’s National Testing Agency (NTA) had also given students an option to change their opted centres for the two tests as students have moved to different places since the lockdown.

The HRD Minister said that a decision will be taken on pending CBSE 10th and 12th Class board exams soon. The two crucial exams were postponed due to the lockdown imposed in the country to combat COVID-19.

Crucially, the minister said that for the next academic year, students will have to learn a reduced syllabus. The HRD minister informed that the syllabus will be reduced for the upcoming academic session as students have lost valuable academic time. Thus the JEE Main and NEET 2021 will be held on the reduced syllabus


The syllabus for the upcoming academic session of schools will be reduced, Human Resource Development (HRD) Minister Ramesh Pokhriyal Nishank today informed during the second live interaction with students through social media platforms. He said the decision has been taken considering the pressure on students and the loss of important academic time.

“CBSE will assess the loss of instructional time for a proportionate reduction in curriculum load for exams. In accordance, course committees of the Board has initiated work on the reduced syllabus in various scenarios,” states an official statement from the ministry.

Universities and schools across the country have been closed since March 16, when the Centre announced a countrywide classroom shutdown as one of the measures to contain the COVID-19 outbreak. Later, a nationwide lockdown was announced from March 25 which will last till May 17.

Continue Reading
Comments

COVID19

COVID-19: India’s Coronavirus Recovery Rate Now More Than 92%

There has been a commensurate dip in the fatality rate which stands at 1.49 per cent.

Published

on

NEW DELHI: India has achieved another significant milestone in its fight against COVID, as more than 76 lakh people have recovered from the infection so far. The national recovery rate has reached 92.09 per cent.

With the overall recovery of nearly 76,56,000 patients, the recovered cases in the country stand at over 14 times the number of active cases.

Over 53,000 patients recovered and were discharged in the last 24 hours whereas the new confirmed cases reported in the same time span stood at nearly 46 thousand.


The active caseload of the country has also fallen below 6.5 per cent.

The total positive cases in the country today stands at 5,33,787 which comprises merely 6.42 per cent of the total reported cases.

With a high number of COVID patients recovering every day along with a steadily falling and sustained low mortality rate, India’s trend of registering decreasing active cases continues.


Health Ministry said that enhanced countrywide medical infrastructure, implementation of the Centre’s Standard Treatment Protocol by the States and Union Territories and total dedication and commitment of doctors, paramedics and frontline workers have led to a persistent increase in the number of total recoveries in the country.

It said that this has also led to a commensurate dip in the fatality rate which stands at 1.49 per cent.

The Health Ministry informed that 514 case fatalities were reported in the past 24 hours of which nearly 75 per cent are concentrated in ten States and Union Territories.

Continue Reading

COVID19

COVID-19: Clinical Trial Of Ayurvedic Remedy Shows Encouraging Results

Over 85% of patients on the natural protocol tested negative for coronavirus on day 5.

Published

on

MUMBAI (Maharashtra): A groundbreaking interim report on a clinical trial being conducted in three hospitals has shown that Covid-19 patients on natural treatment are resolving most symptoms earlier than those on conventional medicines. The interim report on a combination treatment of an Ayurvedic remedy called ‘Immunofree’ by Corival Life Sciences, and Nutraceutical called ‘Reginmune’ by Biogetica have shown exceptional results as against the present government SOP of conventional medicines for coronavirus treatment.

When compared with conventional treatments for COVID-19, Ayurvedic treatment has shown quicker improvement too. 86.66 per cent of patients undergoing a natural treatment tested negative by the fifth day vs 60 per cent patients on conventional treatment.

On the 10th day, all patients tested negative for the virus after Ayurvedic treatment.

Furthermore, numerous tests such as C reactive protein, Procalcitonin, D Dimer and RT-PCR for novel coronavirus are also showing 20 to 60 per cent better improvement for the natural treatment, when compared to conventional treatment.


Numerous subjective endpoints such as body pain and fatigue are also leaning towards natural treatment. Both Clinician’s Global Assessment of Symptoms and Subject’s Global Assessment of Symptoms clearly showed improvements on both arms showing more significant data in the test group.

The three hospitals where Ayurvedic clinical trials are taking place in India are Government Medical Hospital, Srikakulam Andhra Pradesh; Parul Sevashram Hospital, Vadodara, Gujarat, and Lokmanya Hospital Pune, Maharashtra.

The conventional treatment in use depends on the severity of the patient and includes HCQ, Azithromycin, Favipiravir and Cetirizine. This trial also has broader inclusion criteria than others conducted on natural medicine as it includes patients up to 70 years old, with low oxygen saturation and co-morbidities.


It is significant to note that none of the patients on the natural treatment progressed past moderate, needed ventilators or had any adverse events. These precedent-setting results have led to accelerated enrolment into this trial and statistically significant results should be ready by month-end.

Continue Reading

COVID19

COVID-19: IIT Kharagpur Develops Telemedicine Tech For Corona Homecare

The system is accessible by any standard internet browser and also from a mobile device.

Published

on

KHARAGPUR (West Bengal): Amid the world, and India, struggling with the mayhem caused by COVID-19 pandemic. researchers at IIT Kharagpur’s Department of Computer Science & Engineering have developed a telemedicine system, iMediX.

The system integrates homecare with healthcare services from the hospital. Considering the emergent needs due to the pandemic, the system facilitates critical health care support to the patients at their doorsteps through remote consultation by a physician.

The system is accessible by any standard internet browser and also from a mobile device.

In this system, a patient signs up to get an account by providing his/her Email ID or Mobile number. Then the patient can make a request for consultation by choosing a Department of the hospital, entering the chief complaints and uploading necessary scanned medical records. The hospital administration processes the request and assigns a doctor. The doctor after logging in sets an appointment date and time for the patient and the system communicates the information to the patient by Email and SMS. On the day of the visit, the doctor consults the patient using video conferencing and advises the patient by writing a prescription, which is sent by Email to the patient. The patient can also download the prescription from his or her account.


Prof. Jayanta Mukhopadhyay, the lead researcher in this field remarked, “As the number of cases of home isolation and home quarantine is increasing, the system will cater to the needs of the present situation. It would be useful also to follow up and treat aged patients.”

iMedX is being adopted for public use right at its home, IIT Kharagpur on-campus healthcare system.

Director, Prof. V K Tewari stated, “In April we had announced eight R&D projects for providing COVID healthcare services. This telemedicine project is the key among them, especially, keeping in mind its effectiveness in our own community. When our campus will start operating in full strength close to 30000 people including students would be in need of healthcare services and this technology will reduce over-exposure of the healthcare staff while efficiently catering to the population. While we are promoting physical distancing, it seems only appropriate to introduce this digital platform to meet the healthcare needs of the campus community effectively. We are creating user accounts for our medical cardholders who can avail the consultation facility home through video conferencing”.

The software was launched on October 2, 2020, on the occasion of Gandhi Jayanti and will be integrated at the Dr B. C. Roy Technology Hospital of the Institute which provides emergency healthcare services for the campus residents and employees, confirmed the office of Principal Medical Officer Dr Samir Dasgupta.


Deputy Director, Prof. S K Bhattacharyya remarked, “Since we have a large number of OPD patients, it will be extremely beneficial to them as the movement to the hospital is extremely difficult for them. Also, for our students, the waiting time at the hospital will get reduced as this will be very helpful to them.”

A base model was installed at Swasthya Bhawan, Govt. of West Bengal on trial basis. Field trials are also underway for the base model at Bangladesh.

Director Tewari further shared his plan to expand the use of this technology to the people outside the campus through the upcoming super-speciality hospital of IIT Kharagpur.

The researchers are already in touch with healthcare MSMEs for commercialization of the copyrighted version of the technology.

Continue Reading

Most Read This Month

error: Content on this news portal is protected!